Tag:
EMEA application
Latest Headlines
Latest Headlines
Cell Therapeutics pulls EU application for lung drug
Cell Therapeutics has withdrawn its European application to market lung cancer drug Opaxio. In announcing the setback earlier this week, the company cited the concerns of an EMEA committee regarding
Medicines Co. withdraws EMEA application for antibiotic
The Medicines Company says it's no longer seeking EMEA approval to market its investigational antibiotic, oritavancin, after the agency indicated that it would need additional data before considering
